189 related articles for article (PubMed ID: 22705595)
1. Clinical and prognostic role of annexin A2 in multiple myeloma.
Seckinger A; Meissner T; Moreaux J; Depeweg D; Hillengass J; Hose K; Rème T; Rösen-Wolff A; Jauch A; Schnettler R; Ewerbeck V; Goldschmidt H; Klein B; Hose D
Blood; 2012 Aug; 120(5):1087-94. PubMed ID: 22705595
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma.
Bao H; Jiang M; Zhu M; Sheng F; Ruan J; Ruan C
Int J Hematol; 2009 Sep; 90(2):177-185. PubMed ID: 19585213
[TBL] [Abstract][Full Text] [Related]
3. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
4. Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.
Hose D; Rème T; Hielscher T; Moreaux J; Messner T; Seckinger A; Benner A; Shaughnessy JD; Barlogie B; Zhou Y; Hillengass J; Bertsch U; Neben K; Möhler T; Rossi JF; Jauch A; Klein B; Goldschmidt H
Haematologica; 2011 Jan; 96(1):87-95. PubMed ID: 20884712
[TBL] [Abstract][Full Text] [Related]
5. Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment.
D'Souza S; Kurihara N; Shiozawa Y; Joseph J; Taichman R; Galson DL; Roodman GD
Blood; 2012 Feb; 119(8):1888-96. PubMed ID: 22223826
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis-inducing effect of annexin A2 on multiple myeloma cells and its related mechanisms].
Bao HY; Wang JN; Hou YQ; Song M; Zhang LB; Meng QQ; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1384-8. PubMed ID: 23257438
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma.
Li X; Nie S; Lv Z; Ma L; Song Y; Hu Z; Hu X; Liu Z; Zhou G; Dai Z; Song T; Liu J; Wang S
Cell Death Dis; 2021 Mar; 12(3):261. PubMed ID: 33712571
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
[TBL] [Abstract][Full Text] [Related]
9. Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells.
Zhou W; Zhang Y; Zeng Y; Peng M; Li H; Sun S; Ma B; Wang Y; Ye M; Liu J
Biochimie; 2018 Aug; 151():150-158. PubMed ID: 29906496
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
12. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
13. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.
Glavey SV; Naba A; Manier S; Clauser K; Tahri S; Park J; Reagan MR; Moschetta M; Mishima Y; Gambella M; Rocci A; Sacco A; O'Dwyer ME; Asara JM; Palumbo A; Roccaro AM; Hynes RO; Ghobrial IM
Leukemia; 2017 Nov; 31(11):2426-2434. PubMed ID: 28344315
[TBL] [Abstract][Full Text] [Related]
14. Annexin A2: its molecular regulation and cellular expression in cancer development.
Wang CY; Lin CF
Dis Markers; 2014; 2014():308976. PubMed ID: 24591759
[TBL] [Abstract][Full Text] [Related]
15. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
16. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance.
Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW
Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
Seckinger A; Meissner T; Moreaux J; Goldschmidt H; Fuhler GM; Benner A; Hundemer M; Rème T; Shaughnessy JD; Barlogie B; Bertsch U; Hillengass J; Ho AD; Pantesco V; Jauch A; De Vos J; Rossi JF; Möhler T; Klein B; Hose D
Oncogene; 2009 Nov; 28(44):3866-79. PubMed ID: 19718049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
